These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 23974363)

  • 21. [Recent advancements in prostate cancer basic research].
    Inoue T; Ogawa O
    Nihon Rinsho; 2016 Jan; 74(1):7-12. PubMed ID: 26793872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of complex genomic rearrangements in cancers using CouGaR.
    Dzamba M; Ramani AK; Buczkowicz P; Jiang Y; Yu M; Hawkins C; Brudno M
    Genome Res; 2017 Jan; 27(1):107-117. PubMed ID: 27986820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PTEN genomic deletion is an early event associated with ERG gene rearrangements in prostate cancer.
    Bismar TA; Yoshimoto M; Vollmer RT; Duan Q; Firszt M; Corcos J; Squire JA
    BJU Int; 2011 Feb; 107(3):477-85. PubMed ID: 20590547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer genomics: coming in waves.
    Seton-Rogers S
    Nat Rev Cancer; 2013 Jun; 13(6):379. PubMed ID: 23702923
    [No Abstract]   [Full Text] [Related]  

  • 25. DNA alterations in the tumor genome and their associations with clinical outcome in prostate cancer.
    Liu W
    Asian J Androl; 2016; 18(4):533-42. PubMed ID: 26975494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-risk prostate cancer: a disease of genomic instability.
    Tapia-Laliena MA; Korzeniewski N; Hohenfellner M; Duensing S
    Urol Oncol; 2014 Nov; 32(8):1101-7. PubMed ID: 24931269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of chromosomal rearrangements involving non-ETS genes in prostate cancer.
    Kluth M; Galal R; Krohn A; Weischenfeldt J; Tsourlakis C; Paustian L; Ahrary R; Ahmed M; Scherzai S; Meyer A; Sirma H; Korbel J; Sauter G; Schlomm T; Simon R; Minner S
    Int J Oncol; 2015 Apr; 46(4):1637-42. PubMed ID: 25625310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chromoanagenesis: a piece of the macroevolution scenario.
    Pellestor F; Gatinois V
    Mol Cytogenet; 2020; 13():3. PubMed ID: 32010222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assembly of methylated KDM1A and CHD1 drives androgen receptor-dependent transcription and translocation.
    Metzger E; Willmann D; McMillan J; Forne I; Metzger P; Gerhardt S; Petroll K; von Maessenhausen A; Urban S; Schott AK; Espejo A; Eberlin A; Wohlwend D; Schüle KM; Schleicher M; Perner S; Bedford MT; Jung M; Dengjel J; Flaig R; Imhof A; Einsle O; Schüle R
    Nat Struct Mol Biol; 2016 Feb; 23(2):132-9. PubMed ID: 26751641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Co-regulation analysis of closely linked genes identifies a highly recurrent gain on chromosome 17q25.3 in prostate cancer.
    Bermudo R; Abia D; Ferrer B; Nayach I; Benguria A; Zaballos A; del Rey J; Miró R; Campo E; Martínez-A C; Ortiz AR; Fernández PL; Thomson TM
    BMC Cancer; 2008 Oct; 8():315. PubMed ID: 18973659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular Evolution of Early-Onset Prostate Cancer Identifies Molecular Risk Markers and Clinical Trajectories.
    Gerhauser C; Favero F; Risch T; Simon R; Feuerbach L; Assenov Y; Heckmann D; Sidiropoulos N; Waszak SM; Hübschmann D; Urbanucci A; Girma EG; Kuryshev V; Klimczak LJ; Saini N; Stütz AM; Weichenhan D; Böttcher LM; Toth R; Hendriksen JD; Koop C; Lutsik P; Matzk S; Warnatz HJ; Amstislavskiy V; Feuerstein C; Raeder B; Bogatyrova O; Schmitz EM; Hube-Magg C; Kluth M; Huland H; Graefen M; Lawerenz C; Henry GH; Yamaguchi TN; Malewska A; Meiners J; Schilling D; Reisinger E; Eils R; Schlesner M; Strand DW; Bristow RG; Boutros PC; von Kalle C; Gordenin D; Sültmann H; Brors B; Sauter G; Plass C; Yaspo ML; Korbel JO; Schlomm T; Weischenfeldt J
    Cancer Cell; 2018 Dec; 34(6):996-1011.e8. PubMed ID: 30537516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Poly-gene fusion transcripts and chromothripsis in prostate cancer.
    Wu C; Wyatt AW; McPherson A; Lin D; McConeghy BJ; Mo F; Shukin R; Lapuk AV; Jones SJ; Zhao Y; Marra MA; Gleave ME; Volik SV; Wang Y; Sahinalp SC; Collins CC
    Genes Chromosomes Cancer; 2012 Dec; 51(12):1144-53. PubMed ID: 22927308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defining the diverse spectrum of inversions, complex structural variation, and chromothripsis in the morbid human genome.
    Collins RL; Brand H; Redin CE; Hanscom C; Antolik C; Stone MR; Glessner JT; Mason T; Pregno G; Dorrani N; Mandrile G; Giachino D; Perrin D; Walsh C; Cipicchio M; Costello M; Stortchevoi A; An JY; Currall BB; Seabra CM; Ragavendran A; Margolin L; Martinez-Agosto JA; Lucente D; Levy B; Sanders SJ; Wapner RJ; Quintero-Rivera F; Kloosterman W; Talkowski ME
    Genome Biol; 2017 Mar; 18(1):36. PubMed ID: 28260531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of chromosomal and array-based comparative genomic hybridization for the detection of genomic imbalances in primary prostate carcinomas.
    Ribeiro FR; Henrique R; Hektoen M; Berg M; Jerónimo C; Teixeira MR; Lothe RA
    Mol Cancer; 2006 Sep; 5():33. PubMed ID: 16952311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Architectures of somatic genomic rearrangement in human cancer amplicons at sequence-level resolution.
    Bignell GR; Santarius T; Pole JC; Butler AP; Perry J; Pleasance E; Greenman C; Menzies A; Taylor S; Edkins S; Campbell P; Quail M; Plumb B; Matthews L; McLay K; Edwards PA; Rogers J; Wooster R; Futreal PA; Stratton MR
    Genome Res; 2007 Sep; 17(9):1296-303. PubMed ID: 17675364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcriptome sequencing in prostate cancer identifies inter-tumor heterogeneity.
    Mendonca J; Sharma A; Kachhap S
    Asian J Androl; 2015; 17(3):435-6. PubMed ID: 25532579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dysregulated Transcriptional Control in Prostate Cancer.
    Baumgart SJ; Nevedomskaya E; Haendler B
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31200487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The genomic evolution of human prostate cancer.
    Mitchell T; Neal DE
    Br J Cancer; 2015 Jul; 113(2):193-8. PubMed ID: 26125442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single cell genomics reveals activation signatures of endogenous SCAR's networks in aneuploid human embryos and clinically intractable malignant tumors.
    Glinsky GV
    Cancer Lett; 2016 Oct; 381(1):176-93. PubMed ID: 27497790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene expression alterations in human prostate cancer.
    Luo JH
    Drugs Today (Barc); 2002 Oct; 38(10):713-9. PubMed ID: 12582456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.